Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review
-
Published:2024-10
Issue:2
Volume:120
Page:359-369
-
ISSN:0360-3016
-
Container-title:International Journal of Radiation Oncology*Biology*Physics
-
language:en
-
Short-container-title:International Journal of Radiation Oncology*Biology*Physics
Author:
Li George J.ORCID,
Tan Hendrick,
Nusrat Humza,
Chang Joe,
Chen Hanbo,
Poon Ian,
Shahi Jeevin,
Tsao May,
Ung Yee,
Cheung Patrick,
Louie Alexander V.
Reference46 articles.
1. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial;Ball;Lancet Oncol,2019
2. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): Long-term results of a single-arm, prospective trial with prespecified comparison to surgery;Chang;Lancet Oncol,2021
3. Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): Extended long-term outcomes;Harrow;Int J Radiat Oncol,2022
4. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study;Gomez;J Clin Oncol,2019
5. Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer;Timmerman;JAMA Oncol,2018